These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 9828147)
1. Despite its homology to angiostatin apolipoprotein(a) does not affect angiogenesis. Lou XJ; Kwan HH; Prionas SD; Yang ZJ; Lawn RM; Fajardo LF Exp Mol Pathol; 1998 Oct; 65(2):53-63. PubMed ID: 9828147 [TBL] [Abstract][Full Text] [Related]
2. Angiostatin inhibits pathological but not physiological retinal angiogenesis. Drixler TA; Borel Rinkes IH; Ritchie ED; Treffers FW; van Vroonhoven TJ; Gebbink MF; Voest EE Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3325-30. PubMed ID: 11726640 [TBL] [Abstract][Full Text] [Related]
3. Angiostatin: an endogenous inhibitor of angiogenesis and of tumor growth. O'Reilly MS EXS; 1997; 79():273-94. PubMed ID: 9002223 [TBL] [Abstract][Full Text] [Related]
4. Angiostatin enhances B7.1-mediated cancer immunotherapy independently of effects on vascular endothelial growth factor expression. Sun X; Kanwar JR; Leung E; Lehnert K; Wang D; Krissansen GW Cancer Gene Ther; 2001 Oct; 8(10):719-27. PubMed ID: 11687895 [TBL] [Abstract][Full Text] [Related]
5. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3). Chang PC; Chang YJ; Wu HL; Chang CW; Lin CI; Wang WC; Shi GY Thromb Haemost; 2008 Apr; 99(4):729-38. PubMed ID: 18392331 [TBL] [Abstract][Full Text] [Related]
6. Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis. Hajitou A; Sounni NE; Devy L; Grignet-Debrus C; Lewalle JM; Li H; Deroanne CF; Lu H; Colige A; Nusgens BV; Frankenne F; Maron A; Yeh P; Perricaudet M; Chang Y; Soria C; Calberg-Bacq CM; Foidart JM; Noël A Cancer Res; 2001 Apr; 61(8):3450-7. PubMed ID: 11309307 [TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein(a), a link between atherosclerosis and tumor angiogenesis. Trieu VN; Uckun FM Biochem Biophys Res Commun; 1999 Apr; 257(3):714-8. PubMed ID: 10208849 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a). Kim JS; Chang JH; Yu HK; Ahn JH; Yum JS; Lee SK; Jung KH; Park DH; Yoon Y; Byun SM; Chung SI J Biol Chem; 2003 Aug; 278(31):29000-8. PubMed ID: 12746434 [TBL] [Abstract][Full Text] [Related]
9. A novel strategy for the tumor angiogenesis-targeted gene therapy: generation of angiostatin from endogenous plasminogen by protease gene transfer. Matsuda KM; Madoiwa S; Hasumi Y; Kanazawa T; Saga Y; Kume A; Mano H; Ozawa K; Matsuda M Cancer Gene Ther; 2000 Apr; 7(4):589-96. PubMed ID: 10811477 [TBL] [Abstract][Full Text] [Related]
13. Mouse macrophage metalloelastase generates angiostatin from plasminogen and suppresses tumor angiogenesis in murine colon cancer. Xu Z; Shi H; Li Q; Mei Q; Bao J; Shen Y; Xu J Oncol Rep; 2008 Jul; 20(1):81-8. PubMed ID: 18575722 [TBL] [Abstract][Full Text] [Related]
14. Characterization and biological activities of recombinant human plasminogen kringle 1-3 produced in Escherichia coli. You WK; So SH; Sohn YD; Lee H; Park DH; Chung SI; Chung KH Protein Expr Purif; 2004 Jul; 36(1):1-10. PubMed ID: 15177278 [TBL] [Abstract][Full Text] [Related]
15. [Inhibitory effects of murine angiostatin on implant carcinoma of nude mouse]. Tao K; Wu X; Dou K Zhonghua Wai Ke Za Zhi; 2002 Aug; 40(8):621-4. PubMed ID: 12417081 [TBL] [Abstract][Full Text] [Related]
16. Angiostatin inhibits extracellular HIV-Tat-induced inflammatory angiogenesis. Benelli R; Morini M; Brigati C; Noonan DM; Albini A Int J Oncol; 2003 Jan; 22(1):87-91. PubMed ID: 12469189 [TBL] [Abstract][Full Text] [Related]
17. A versatile in vivo chamber angiogenesis assay for measuring anti-angiogenic activity in mice. Kragh M; Hjarnaa PJ; Bramm E; Binderup L Oncol Rep; 2004 Feb; 11(2):303-7. PubMed ID: 14719059 [TBL] [Abstract][Full Text] [Related]
18. The therapeutic efficacy of angiostatin against weakly- and highly-immunogenic 3LL tumors. Li M; Huang X; Zhu Z; Zhao Q; Wong M; Gorelik E In Vivo; 2002; 16(6):577-82. PubMed ID: 12494903 [TBL] [Abstract][Full Text] [Related]
19. Neutrophils as a key cellular target for angiostatin: implications for regulation of angiogenesis and inflammation. Benelli R; Morini M; Carrozzino F; Ferrari N; Minghelli S; Santi L; Cassatella M; Noonan DM; Albini A FASEB J; 2002 Feb; 16(2):267-9. PubMed ID: 11772950 [TBL] [Abstract][Full Text] [Related]